AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 1776352
Drug: Retrograde Venous
RxNorm normalized name: bushmaster venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Retrograde Venous Perfusion (RVP) treatment
Trial: 1776352
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (CG) treated with systemic i.v. infusions
Trial: 1776352
Drug: RVP treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RVP treatment in patients with secondary osteomyelitis
Trial: 1776352
Drug: RVP treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RVP treatment
Trial: 6894606
Drug: Subcutaneous killed
RxNorm normalized name: Hongo Killer
DrugBank: Undecylenic acid (DB11117)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Subcutaneous killed poliovirus vaccine
Trial: 6894606
Drug: Subcutaneous poliovirus
RxNorm normalized name: poliovirus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous poliovirus vaccination
Trial: 6894606
Drug: Peroral liver
RxNorm normalized name: LIVER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peroral liver poliovirus vaccine
Trial: 6894606
Drug: Peroral liver
RxNorm normalized name: LIVER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peroral liver poliovirus vaccine with subcutaneous killed Vibrio cholerae vaccine
Trial: 26253887
Drug: Methylprednisolone (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylprednisolone (1 g intraoperatively and 15 mg/kg for an additional 3 days)
Trial: 22684738
Drug: Remifentanil Ce
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remifentanil Ce = 2 ng ml(‐1)
Trial: 22684738
Drug: Remifentanil Ce
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remifentanil Ce = 4 ng ml(‐1)
Trial: 17084395
Drug: hCG administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: hCG administration during IVF cycles
Trial: 17084395
Drug: Declining E(2)
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Declining E(2) levels after hCG administration
Trial: 15692762
Drug: Doxorubicin 75
RxNorm normalized name: DOXOrubicin 75 mg intravenous powder for injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxorubicin 75 mg/M2 q2 wks x 3 and docetaxel 40 mg/M2 weekly x 6
Trial: 10599371
Drug: Tauredon (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tauredon (50 mg/week intramuscularly)
Trial: 7818648
Drug: Bendrofluazide 1.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bendrofluazide 1.25 mg
Trial: 7818648
Drug: Bendrofluazide 5.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bendrofluazide 5.0 mg
Trial: 6110384
Drug: Temazepam 20
RxNorm normalized name: temazepam 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Temazepam 20 mg or 30 mg orally 1 hour before surgery
Trial: 31577875
Drug: Isoniazid preventive
RxNorm normalized name: Isoniazid
DrugBank: Isoniazid (DB00951)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isoniazid preventive therapy for 28 weeks (immediate group)
Trial: 31577875
Drug: Isoniazid preventive
RxNorm normalized name: Isoniazid
DrugBank: Isoniazid (DB00951)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isoniazid preventive therapy for 28 weeks (deferred group)
Trial: 31577875
Drug: Isoniazid preventive
RxNorm normalized name: Isoniazid
DrugBank: Isoniazid (DB00951)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isoniazid preventive therapy (immediate group)
Trial: 31577875
Drug: Isoniazid preventive
RxNorm normalized name: Isoniazid
DrugBank: Isoniazid (DB00951)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isoniazid preventive therapy (deferred group)
Trial: 29632870
Drug: Dopamine D2/D3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dopamine D2/D3 receptor antagonist sulpiride
Trial: 26657824
Drug: Loulla (liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loulla (liquid formulation of 6-mercaptopurine)
Trial: 26657824
Drug: Registered tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Registered tablets (control)
Trial: 12378877
Drug: Psychopharmacotherapy combined
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychopharmacotherapy combined with cognitive behavioural therapy
Trial: 8793607
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg diclofenac
Trial: 1638335
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg disulfiram
Trial: 10594487
Drug: 250 ml
RxNorm normalized name: TPN Bag 250 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 ml grapefruit juice twice daily
Trial: 10594487
Drug: 250 mg
RxNorm normalized name: rutin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg erythromycin 4 times daily
Trial: 26874645
Drug: Tolvaptan (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tolvaptan (15 mg/d, titrated to 30 or 60 mg/d)
Trial: 17506866
Drug: Cardio-selective beta(1)-adrenergic
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cardio-selective beta(1)-adrenergic blockade (0.15 mg kg(‐1) metoprolol)
Trial: 11927516
Drug: Inhalation of
RxNorm normalized name: Ocean brand of sodium chloride Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation of concentrated ambient fine particles (CAP) plus ozone (120 ppb) for 2 hours
Trial: 11927516
Drug: Filtered air
RxNorm normalized name: air
DrugBank: Medical air (DB09337)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Filtered air inhalation
Trial: 8137988
Drug: Corticosteroid treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroid treatment to induce immunosuppression
Trial: 22032343
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (650 ml tea)
Trial: 16911649
Drug: Topical racemic
RxNorm normalized name: EPINEPHRINE,RACEMIC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical racemic adrenaline (RA) 1:500
Trial: 9166464
Drug: No adjuvant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No adjuvant systemic therapy
Trial: 10681072
Drug: Losartan (50-100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan (50-100 mg)
Trial: 31012566
Drug: Epicutaneous heat
RxNorm normalized name: norethindrone
DrugBank: Norethisterone (DB00717)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epicutaneous heat patch applied for 2 hours per day for 12 weeks
Trial: 31012566
Drug: Epicutaneous heat
RxNorm normalized name: norethindrone
DrugBank: Norethisterone (DB00717)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epicutaneous heat patch
Trial: 21916638
Drug: Malaria vaccine
RxNorm normalized name: malaria vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Malaria vaccine FMP2.1/AS02(A)
Trial: 19806414
Drug: No Treatment
RxNorm normalized name: NO
DrugBank: Nitric Oxide (DB00435)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No Treatment Control (C)
Trial: 11411059
Drug: Metformin (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (2 x 850 mg)
Trial: 8677878
Drug: Epinephrine infusion
RxNorm normalized name: Epinephrine
DrugBank: Epinephrine (DB00668)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epinephrine infusion at dosages of 10 to 320 ng/kg/min
Trial: 8677878
Drug: Epinephrine infusion
RxNorm normalized name: Epinephrine
DrugBank: Epinephrine (DB00668)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epinephrine infusion at dosages of 40 ng/kg/min
Trial: 8677878
Drug: Epinephrine infusion
RxNorm normalized name: Epinephrine
DrugBank: Epinephrine (DB00668)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epinephrine infusion at dosages > 80 ng/kg/min
Trial: 31036542
Drug: NP-S +
RxNorm normalized name: NP Thyroid Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NP-S + GM-CSF (1,000 μg NP-S + 250 μg GM-CSF monthly for 6 months, then every 6 months through 36 months)
Trial: 31036542
Drug: Placebo +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo + GM-CSF (monthly for 6 months, then every 6 months through 36 months)
Trial: 2510657
Drug: Cadralazine 10
RxNorm normalized name: cadralazine
DrugBank: Cadralazine (DB13452)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cadralazine 10 mg o.d.
Trial: 1159434
Drug: Anticoagulants for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anticoagulants for an average period of 18 months
Trial: 28835271
Drug: 4000 IU
RxNorm normalized name: Cholecalciferol 4000 IU Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4000 IU vitamin D3 daily
Trial: 25877802
Drug: Zinc Glycinate
RxNorm normalized name: Zinc Glycinate
DrugBank: Zinc glycinate citrate (DB15556)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc Glycinate (60 mg Zn/day)
Trial: 25877802
Drug: Zinc Gluconate
RxNorm normalized name: Zinc Gluconate
DrugBank: Zinc gluconate (DB11248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Zinc Gluconate (60 mg Zn/day)
Trial: 24157649
Drug: EHR-based medication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EHR-based medication management tools alone
Trial: 24157649
Drug: EHR tools
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EHR tools plus nurse-led medication therapy management
Trial: 21748203
Drug: Misoprostol 50
RxNorm normalized name: diclofenac-misoprostol 50 mg-200 mcg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Misoprostol 50 μg intravaginally every 4 hours (maximum 6 doses)
Trial: 6785336
Drug: Symptomatic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Symptomatic therapy
Trial: 8368410
Drug: Diclofenac, 75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac, 75 mg twice daily for 3 to 5 days before and for 7 days after surgery
Trial: 27184170
Drug: Alirocumab 150
RxNorm normalized name: alirocumab 150 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alirocumab 150 mg
Trial: 27595147
Drug: pexacerfont (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pexacerfont (300 mg/day for 7 days, then 100 mg/day for 21 days)
Trial: 18788033
Drug: Unipolar RF
RxNorm normalized name: Aminosyn-RF 5.2 %, Sulfite-Free
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unipolar RF treatment
Trial: 18727024
Drug: Bipolar RF
RxNorm normalized name: Aminosyn-RF 5.2 %, Sulfite-Free
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bipolar RF treatment
Trial: 10030326
Drug: Intensive treatment
RxNorm normalized name: Head & Shoulders Intensive Treatment
DrugBank: Selenium Sulfide (DB00971)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive treatment (stepwise implementation of behaviour modification, pharmacological therapy targeting hyperglycaemia, hypertension, dyslipidaemia, and microalbuminuria)
Trial: 10030326
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment (followed Danish guidelines)
Trial: 7575052
Drug: Symptomatic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Symptomatic treatment alone (prednisolone)
Trial: 2341751
Drug: High-dose human
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose human leukocyte interferon-alpha (IFN-alpha)
Trial: 7396099
Drug: Nicotinic acid
RxNorm normalized name: Nicotinic acid
DrugBank: Niacin (DB00627)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotinic acid (i.v. administered)
Trial: 25918727
Drug: sulodexide 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sulodexide 100 mg/day for 14 weeks
Trial: 19542797
Drug: Microcurrent therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Microcurrent therapy (MCT) patch
Trial: 17854237
Drug: Hydralazine capsule
RxNorm normalized name: hydralazine Oral Capsule
DrugBank: Hydralazine (DB01275)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hydralazine capsule plus ISDN tablet (V‐HeFT I formulation)
Trial: 17854237
Drug: Hydralazine tablet
RxNorm normalized name: hydralazine Oral Tablet
DrugBank: Hydralazine (DB01275)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hydralazine tablet plus ISDN tablet (V‐HeFT II formulation)
Trial: 17854237
Drug: FDC ISDN/HYD
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FDC ISDN/HYD (A‐HeFT formulation)
Trial: 11543695
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of methotrexate, sulfasalazine, and hydroxychloroquine
Trial: 11543695
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of methotrexate and cyclosporin
Trial: 11543695
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of anti-TNF therapy with methotrexate
Trial: 11543695
Drug: Corticosteroids in
RxNorm normalized name: abiraterone and corticosteroids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroids in addition to the combination therapies
Trial: 11543695
Drug: Other combinations
RxNorm normalized name: Iron in other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other combinations involving parenteral gold, penicillamine, and azathioprine
Trial: 9600553
Drug: Intramuscular botulinum
RxNorm normalized name: Clostridium botulinum
DrugBank: Clostridium botulinum (DB14223)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular botulinum toxin A (BtA)
Trial: 7973470
Drug: Psychoeducational family
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychoeducational family management with standard dose or targeted medication
Trial: 2681764
Drug: Continuous allopurinol
RxNorm normalized name: Allopurinol
DrugBank: Allopurinol (DB00437)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Continuous allopurinol therapy
Trial: 2681764
Drug: Intermittent allopurinol
RxNorm normalized name: Allopurinol
DrugBank: Allopurinol (DB00437)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intermittent allopurinol therapy (2 months every year)
Trial: 18326616
Drug: Isoflavone-enriched foods
RxNorm normalized name: ALLERGENIC EXTRACT, FOOD, WHEAT
DrugBank: Wheat (DB10579)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isoflavone-enriched foods providing a mean daily intake of 110 mg isoflavone aglycones
Trial: 14740274
Drug: Insulin glargine
RxNorm normalized name: Insulin Glargine
DrugBank: Insulin glargine (DB00047)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin glargine (0.1 IU/kg)
Trial: 14740274
Drug: Regular human
RxNorm normalized name: insulin regular human recombinant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular human insulin (0.1 IU/kg)
Trial: 14740274
Drug: Insulin glargine
RxNorm normalized name: Insulin Glargine
DrugBank: Insulin glargine (DB00047)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin glargine and regular human insulin
Trial: 1299490
Drug: Magnesium supplementation
RxNorm normalized name: Magnesium
DrugBank: Magnesium (DB14513)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnesium supplementation (365 mg per day)
Trial: 31107956
Drug: Azithromycin treatment
RxNorm normalized name: Azithromycin
DrugBank: Azithromycin (DB00207)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Azithromycin treatment
Trial: 30107419
Drug: Combination nicotine
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Combination nicotine patch and lozenge
Trial: 30107419
Drug: Patch monotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patch monotherapy
Trial: 29935535
Drug: Intravenous propacetamol
RxNorm normalized name: 1,2,3-propanetriol, 2-(4-aminobenzoate)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous propacetamol followed by oral placebo
Trial: 29935535
Drug: Oral dexibuprofen
RxNorm normalized name: ibuprofen Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral dexibuprofen after intravenous 0.9% sodium chloride solution
Trial: 25172878
Drug: Low-dose PAZ320
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose PAZ320 (8 g)
Trial: 25172878
Drug: High-dose PAZ320
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose PAZ320 (16 g)
Trial: 20455890
Drug: Individualized GH
RxNorm normalized name: chloroxylenol
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Individualized GH treatment (17-100 microg/kg/day)
Trial: 20455890
Drug: Standard GH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard GH dose treatment (43 microg/kg/day)
Trial: 15994746
Drug: Individualized GH
RxNorm normalized name: chloroxylenol
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Individualized GH treatment
Trial: 12854177
Drug: Sea buckthorn
RxNorm normalized name: sea buckthorn
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sea buckthorn extract, 15 g 3 times a day for 6 months
Trial: 12854177
Drug: Vitamin B
RxNorm normalized name: VITAMIN B
DrugBank: Inositol (DB13178)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin B complex one tablet, 3 times a day for 6 months
Trial: 10702196
Drug: Tegaserod, 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tegaserod, 2 mg twice daily for 1 week
Trial: 8225212
Drug: Propranolol (0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (0.15 mg/kg, intravenously)
Trial: 29478970
Drug: Sitagliptin plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sitagliptin plus GHR antagonist
Trial: 20556256
Drug: Delayed implant
RxNorm normalized name: Drug Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed implant placement (ridge preservation with grafting)
Trial: 18854562
Drug: Amrubicin (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amrubicin (40 mg/m² on days 1-3)
Trial: 18854562
Drug: Topotecan (1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topotecan (1.0 mg/m² on days 1-5)
Trial: 10569660
Drug: Enalapril (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril (20 mg/day) + placebo (E+P)
Trial: 10569660
Drug: Losartan (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan (50 mg/day) + placebo (L+P)
Trial: 10569660
Drug: Enalapril +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril + Losartan (E+L)
Trial: 8702449
Drug: Treatment counseling
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment counseling telephone intervention
Trial: 1649715
Drug: Gliclazide (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gliclazide (80 mg) administered 90 min before glucose clamp
Trial: 30318893
Drug: Propofol (average
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol (average up to 115 mg in boluses of 20 mg) plus placebo (saline solution)
Trial: 30318893
Drug: Midazolam (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (3 mg) plus propofol (average up to 83 mg in boluses of 20 mg)
Trial: 27095338
Drug: Motivational Interviewing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Motivational Interviewing and Cognitive Behavioral Therapy (MICBT) plus standard care
Trial: 11893228
Drug: Old antiepileptic
RxNorm normalized name: Oldenlandia diffusa extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Old antiepileptic drugs (AEDs)
Trial: 7610938
Drug: Alendronate 20
RxNorm normalized name: alendronate
DrugBank: Alendronic acid (DB00630)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alendronate 20 mg
Trial: 19033149
Drug: Internet-based cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Internet-based cognitive behavioral therapy (CBT)
Trial: 21269858
Drug: Single 60‐mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single 60‐mg/kg dose of azithromycin extended‐release (ER)
Trial: 21269858
Drug: 10‐day regimen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10‐day regimen of amoxicillin/clavulanate 90/6.4 mg/kg per day
Trial: 19384185
Drug: Sirolimus (SRL)
RxNorm normalized name: Sirolimus
DrugBank: Sirolimus (DB00877)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Sirolimus (SRL) used as an early drug in a calcineurin inhibitor-free protocol in the first 3 months after transplantation
Trial: 16924010
Drug: IV immunoglobulin
RxNorm normalized name: immunoglobulins, intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV immunoglobulin (IVIg) treatment
Trial: 15675752
Drug: Empirical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Empirical therapy using benzylpenicillin in control group
Trial: 15675752
Drug: Empirical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Empirical therapy using benzylpenicillin in prophylaxis group
Trial: 16403928
Drug: Beta-blocker alone
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-blocker alone
Trial: 16818810
Drug: Amiodarone plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amiodarone plus beta-blocker
Trial: 16403928
Drug: Amiodarone plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amiodarone plus beta-blocker vs beta-blocker alone
Trial: 16403928
Drug: Sotalol vs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sotalol vs beta-blocker alone
Trial: 16403928
Drug: Amiodarone plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amiodarone plus beta-blocker vs sotalol
Trial: 10319306
Drug: Metrogel Vaginal
RxNorm normalized name: MetroGel Vaginal Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metrogel Vaginal (one applicator twice daily for five days)
Trial: 10319306
Drug: Metronidazole (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metronidazole (500 mg twice daily for seven days by mouth)